Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Synagis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Synagis was produced by AstraZeneca and AbbVie.

AstraZeneca/Sanofi’s Beyfortus receives EC approval for prevention of RSV in infants

AstraZeneca/Sanofi’s Beyfortus receives EC approval for prevention of RSV in infants

In the MEDLEY phase 2/3 trials, Beyfortus also demonstrated a comparable safety and tolerability profile to Synagis (palivizumab), with adverse events reportedly similar between groups.

AstraZeneca/Sanofi’s Beyfortus receives CHMP recommendation for prevention of RSV disease in infants

AstraZeneca/Sanofi’s Beyfortus receives CHMP recommendation for prevention of RSV disease in infants In the MEDLEY phase 2/3 trials, Beyfortus also demonstrated a comparable safety and tolerability profile to Synagis (palivizumab), with adverse events reportedly similar between groups.

AstraZeneca blocks take-private buyout of Sobi

AstraZeneca blocks take-private buyout of Sobi Sobi. This came about through a 2018 deal that saw Sobi gain the rights to sell AZ’s respiratory drug Synagis in the US. ... Synagis prevents serious lower respiratory tract infections caused by the respiratory syncytial virus in infants and young

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial

AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial In addition to the MELODY trial, nirsevimab is being evaluated in the phase 2/3 MEDLEY trial, which is assessing the monoclonal antibody (mAb) compared to the older RSV treatment Synagis

Sobi shows strong growth despite haemophilia competition

Sobi shows strong growth despite haemophilia competition November also saw Sobi acquire rights to Synagis, the only approved respiratory syncytial virus (RSV) prophylaxis for high-risk infants from AstraZeneca. ... We completed the acquisition of Synagis in late January and are in the process of integrating

1 2 3 4 5 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Say Communications

We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...

Latest intelligence

Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening...
Meeting1
Reimagining strategy development for a hybrid workforce
By Janice MacLennan...